Showing results (31-40 of 102) with videos related to
Sort By:
Pageof 11
Current Opinion in Rheumatology|April 17, 2012
Infection as a cause of type 1 diabetes?Urs Christen, Christine Bender, Matthias G von HerrathMolecular Immunology|March 17, 2009
The role of the activating receptor NKG2D in autoimmunityTom L Van Belle, Matthias G von HerrathClinical & Developmental Immunology|December 13, 2006
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodiesMette Ejrnaes, Matthias G von Herrath, Urs ChristenScience Advances|October 14, 2020
Interference with pancreatic sympathetic signaling halts the onset of diabetes in miceGustaf Christoffersson, Sowbarnika S Ratliff, Matthias G von HerrathAPMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 12, 2012
Viral infections and molecular mimicry in type 1 diabetesKen T Coppieters, Anna Wiberg, Matthias G von HerrathNature Reviews. Microbiology|March 24, 2004
Microorganisms and autoimmunity: making the barren field fertile?Matthias G von Herrath, Robert S Fujinami, J Lindsay WhittonClinical Immunology (Orlando, Fla.)|July 1, 2015
Immunotherapies and immune biomarkers in Type 1 diabetes: A partnership for successNiels V Rekers, Matthias G von Herrath, Johnna D WesleyClinical Immunology (Orlando, Fla.)|March 16, 2013
Trials in type 1 diabetes: Antigen-specific therapiesKen T Coppieters, Leonard C Harrison, Matthias G von HerrathThe Review of Diabetic Studies : RDS|June 28, 2013
Clinical potential of antigen-specific therapies in type 1 diabetesKen T Coppieters, Birgit Sehested Hansen, Matthias G von HerrathJournal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearanceMatthias G von Herrath, Bryan Coon, Tom Wolfe, et al.Pageof 11